AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Progyny Inc. (PGNY)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

23.91

0.22 (0.93%)

At close: Feb 20, 2025, 3:59 PM

23.88

-0.13%

After-hours: Feb 20, 2025, 04:00 PM EST

undefined% (undefined)

Bid	23.51
Market Cap	2.04B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.6
PE Ratio (ttm)	39.85
Forward PE	n/a
Analyst	Hold

Ask	23.98
Volume	1,018,223
Avg. Volume (20D)	1,789,601
Open	23.57
Previous Close	23.69
Day's Range	22.85 - 23.97
52-Week Range	13.39 - 40.89
Beta	undefined

About PGNY

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the me...

[Show more]

Industry Medical - Healthcare Information Services

Sector Healthcare

IPO Date Oct 25, 2019

Employees 563

Stock Exchange NASDAQ

Ticker Symbol PGNY

Website https://www.progyny.com

Full Company Profile

Analyst Forecast

According to 11 analyst ratings, the average rating for PGNY stock is "Hold." The 12-month stock price forecast is $22, which is a decrease of -7.99% from the latest price.

Buy 18.18%

Hold 63.64%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Progyny Inc. is scheduled to release its earnings on Feb 27, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 months ago

-19.09%

Progyny share shares are trading lower after the c... Unlock content with Pro Subscription

5 months ago

-32.65%

Progyny shares are trading lower after a client elected to exercise an option to terminate its services agreement with the company.

News

1 day ago · zacks.com

Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth

Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 weeks ago · zacks.com

All You Need to Know About Progyny (PGNY) Rating Upgrade to Buy

Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

3 weeks ago · zacks.com

Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?

Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

1 month ago · seekingalpha.com

The Bottom Fishing Club: Progyny Reverses On Heavy Insider Buying

Progyny shares have plummeted nearly 80% from 2021's peak, but management optimism and insider buying in December signal a potential turnaround during 2025. PGNY's valuation is deeply discounted, with...

2 months ago · seekingalpha.com

Progyny: Rating Downgrade On Uncertain Growth Outlook

I recommend downgrading Progyny from buy to hold due to a loss of confidence in its growth outlook and increased uncertainty. PGNY's Q3 2024 results were disappointing, with revenue and margins fallin...